It is estimated that almost twenty-five to thirty-five million Americans consisting of persons of all ages and sex suffer from one or the other form of a degenerative connective tissue disease. These diseases involve complex biochemical changes and, although great progress has been made in our understanding of these changes, the picture is far from complete. In this regard, our long term objective is to fully understand the role(s) of endogenous copper (Cu) and Cu-containing enzymes (e.g. Cu, Zn-Superoxide dismutase, ceruloplasmin (Cp), etc.) in both acute and chronic inflammation. As a follow-up to our current studies, the major specific aims of the present proposal are to 1) carry out mechanistic studies to determine the biochemical/cellular basis of increased carrageenin paw edema (CE) in nutritionally Cu-def. rats; 2) to further investigate the immunosuppressive effects of nutritional Cu-def. on antibody production against Type III pneumococcal polysaccharide (S3) in the rat; and 3) to examine the effects of nutritional Cu-def. on reverse passive Arthus reaction (RPAR) and collagen-induced arthritis (CIA) in the rat. In order to investigate the biochemical/cellular basis of increased CE in Cu-def. rats a series of experiments will be conducted to seek answers to questions such as: do neutrophils from Cu-def. rats generate more superoxide or arachadonic acid metabolites; do Cu-def. rats show increased vascular permeability; are the effects of Cu-def. reversible upon Cu supplementation or upon treatment with Cu, Zn-SOD, Cp, non- steroidal antiinflammatory drugs; do Cu-def. rats still show greater inflammation when the latter is induced by specific mediators, etc. Effects of Cu-def. on antibody production against S3 will be investigated by measuring IgM anti-S3 production after 20, 40, 60 days feeding of a Cu-def. diet and the specificity of the effects will be checked by studying reversibility following Cu supplementation. The effects of Cu- def. on RPAR and CLA will be studied following 60 days feeding of a Cu-def diet. In RPAR, effects of pretreatment with novel antiinflammatory drugs chloroquine and levamisole will be studied. In CLA, the effects will be quantified by measuring the serum concentrations of IgM rat anti-collagen and IgG rat anti- collagen antibodies. In all experiments, Cu-def. or Cu- supplementation will be confirmed by measuring the concentration of Cu and activities of Cu,Zn-SOD, and cp in relevant tissues.

Project Start
Project End
Budget Start
Budget End
Support Year
18
Fiscal Year
1988
Total Cost
Indirect Cost
Name
Xavier University of Louisiana
Department
Type
DUNS #
020857876
City
New Orleans
State
LA
Country
United States
Zip Code
70125
Bazargan, M; Barbre, A R; Hamm, V (1993) Failure to have prescriptions filled among Black elderly. J Aging Health 5:264-82
Ochillo, R F (1991) A working hypothesis of acute stress-induced hypotension. Med Hypotheses 36:179-80
Tsai, C S; Ochillo, R F (1991) Pharmacological effects of berberine on the longitudinal muscle of the guinea-pig isolated ileum. Arch Int Pharmacodyn Ther 310:116-31
Klein, C L; Banks, T A; Rouselle, D (1991) Structure of nortriptyline hydrochloride. Acta Crystallogr C 47 ( Pt 7):1478-80
Tsai, C S; Washington, C; Ochillo, R F (1990) Cardiovascular effects of doxorubicin. Gen Pharmacol 21:729-33
Tsai, C S; Ochillo, R F (1989) Low temperature and muscarinic receptor activities. Cryobiology 26:485-95
Ochillo, R F; Tsai, C S (1988) A comparative study of the effects of aging on the responsiveness of the cholinergic receptor of the isolated ileum of mouse and rat. Res Commun Chem Pathol Pharmacol 60:261-4
Kishore, V (1988) Antiinflammatory activities of copper-aspirinate and aspirin in adjuvant arthritic rats. Res Commun Chem Pathol Pharmacol 60:257-60
Tsai, C S; Ochillo, R F (1988) The effects of hypothermia on the blockade of muscarinic receptors by phenoxybenzamine. Arch Int Pharmacodyn Ther 292:76-85
Tsai, C S; Ochillo, R F (1987) The effects of phenylbutazone on acetylcholine-initiated contractions of gastric muscularis muscle of Bufo marinus. Res Commun Chem Pathol Pharmacol 58:273-6

Showing the most recent 10 out of 14 publications